PMID- 8676344 OWN - NLM STAT- MEDLINE DCOM- 19960815 LR - 20131121 IS - 0022-2623 (Print) IS - 0022-2623 (Linking) VI - 39 IP - 5 DP - 1996 Mar 1 TI - Toward a novel metal-based chemotherapy against tropical diseases. 2. Synthesis and antimalarial activity in vitro and in vivo of new ruthenium- and rhodium-chloroquine complexes. PG - 1095-99 AB - Chloroquine free base (CQ) reacts with [Rh(COD)Cl]2 (COD = 1,5-cyclooctadiene) and RuCl3.-3H2O/Zn to yield Rh(COD)(CQ)Cl (1) and [RuCl2(CQ)]2 (2), respectively. The two novel metal- CQ complexes, which were characterized mainly by 1D and 2D NMR spectroscopy, were tested against Plasmodium berghei. The in vitro activity of 1 was comparable to that of chloroquine diphosphate (CQDP), whereas 2 was about 5 times more active. In in vivo tests at equivalent concentrations of free CQ, CQDP reduced the parasitemia by 55%, while for complexes 1 and 2 the reduction reached 73% and 94%, respectively, without any sign of acute toxicity being observed up to 30 days after treatment. The Ru derivative 2 was further evaluated against two chloroquine-resistant strains of Plasmodium falciparum, and it was found to be 2-5 times more active than CQDP. FAU - Sanchez-Delgado, R A AU - Sanchez-Delgado RA AD - Transition Metal Chemistry, Instituto Venezolano de Investigaciones Cientificas, Caracas, Venezuela. FAU - Navarro, M AU - Navarro M FAU - Perez, H AU - Perez H FAU - Urbina, J A AU - Urbina JA LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - J Med Chem JT - Journal of medicinal chemistry JID - 9716531 RN - 0 (Antimalarials) RN - 0 (Organometallic Compounds) RN - 0 (bis(ruthenium(chloroquine)dichloride)) RN - 0 (rhodium(1,5-cyclooctadiene)(chloroquine)chloride) RN - 886U3H6UFF (Chloroquine) SB - IM MH - Animals MH - Antimalarials/*chemical synthesis/pharmacology/therapeutic use MH - Chloroquine MH - Drug Resistance MH - Female MH - Magnetic Resonance Spectroscopy MH - Malaria/*drug therapy MH - Mice MH - Mice, Inbred BALB C MH - Molecular Structure MH - Organometallic Compounds/*chemical synthesis/pharmacology/therapeutic use MH - Plasmodium berghei/*drug effects MH - Plasmodium falciparum/*drug effects EDAT- 1996/03/01 00:00 MHDA- 1996/03/01 00:01 CRDT- 1996/03/01 00:00 PHST- 1996/03/01 00:00 [pubmed] PHST- 1996/03/01 00:01 [medline] PHST- 1996/03/01 00:00 [entrez] AID - jm950729w [pii] AID - 10.1021/jm950729w [doi] PST - ppublish SO - J Med Chem. 1996 Mar 1;39(5):1095-99. doi: 10.1021/jm950729w.